TRIPS-plus条款的扩张及中国的应对策略——以药品的专利保护为视角
发布时间：2018-08-24 17:58
【摘要】：近年以来,美国与欧盟等发达国家利用TRIPS协议的弹性规定,在与其他国家签订的自由贸易协定中大量加入TRIPS-plus条款。这些条款通过对TRIPS的拓展以及限制来提高知识产权保护标准,在药品的专利保护领域尤为突出。实践证明,TRIPS-plus条款严重影响了发展中国家药品的可及性。我国作为大量依靠仿制药品的发展中国家,在国内立法以及签署自由贸易区协定等国际条约时,应当对TRIPS-plus条款保持高度警惕,审慎引入专利链接制度,为数据独占保护设置限制条件,保留强制许可、平行进口等TRIPS允许的弹性条款,尽量为国内政策预留一些选择空间。
[Abstract]:In recent years, developed countries such as the United States and the European Union have taken advantage of the flexible provisions of TRIPS agreements to add a large number of TRIPS-plus clauses to free trade agreements signed with other countries. These provisions improve the standards of intellectual property protection through the extension and limitation of TRIPS, especially in the field of patent protection of drugs. It has been proved that TRIPS-plus has seriously affected the availability of drugs in developing countries. China, as a developing country that relies heavily on imitation drugs, should be on high alert to the provisions of TRIPS-plus and introduce patent link system prudently in its domestic legislation and signing of international treaties such as free trade zone agreements. It sets restrictions for data exclusive protection, preserves the flexible clauses allowed by TRIPS, such as compulsory license, parallel import, and so on, so as to reserve some choice space for domestic policy as far as possible.
【作者单位】： 重庆大学法学院;
【基金】：国家留学基金委2009年度“青年骨干教师出国研修项目”(20093013)
【分类号】：D997.1
[Abstract]:In recent years, developed countries such as the United States and the European Union have taken advantage of the flexible provisions of TRIPS agreements to add a large number of TRIPS-plus clauses to free trade agreements signed with other countries. These provisions improve the standards of intellectual property protection through the extension and limitation of TRIPS, especially in the field of patent protection of drugs. It has been proved that TRIPS-plus has seriously affected the availability of drugs in developing countries. China, as a developing country that relies heavily on imitation drugs, should be on high alert to the provisions of TRIPS-plus and introduce patent link system prudently in its domestic legislation and signing of international treaties such as free trade zone agreements. It sets restrictions for data exclusive protection, preserves the flexible clauses allowed by TRIPS, such as compulsory license, parallel import, and so on, so as to reserve some choice space for domestic policy as far as possible.
【作者单位】： 重庆大学法学院;
【基金】：国家留学基金委2009年度“青年骨干教师出国研修项目”(20093013)
【分类号】：D997.1
【相似文献】
相关期刊论文 前10条
1 李晓蕾;;关于医疗用途专利新颖性的研究——对默克公司专利无效案的思考[J];知识产权;2010年01期
2 傅利英;于杨曜;张晓东;;“老字号”企业技术创新及专利、商业秘密立体保护措施研究[J];科技与法律;2010年01期
3 杨异;杨超;;网络商业方法专利保护问题研究[J];牡丹江大学学报;2010年01期
4 马元锋;;中国专利国际申请探究——兼评《专利法》第20条修改的积极意义[J];南都学坛;2010年02期
5 肖尤丹;苏竣;;突发公共卫生危机与药品专利强制许可[J];科技与法律;2010年01期
6 罗胜强;赵海燕;;商业成功标准在商业方法专利创造性判断中适用性评析[J];情报杂志;2010年02期
7 朱工宇;;与公共健康有关的TRIPS-plus条款研究——兼论国际知识产权立法的双边趋势[J];世界贸易组织动态与研究;2010年02期
8 李丽娜;;美国专利商标局将改变其专利期限调整评估方法——美国联邦巡回上诉法院判定USPTO错误调整专利保护期限[J];中国发明与专利;2010年03期
9 王楠;游志能;;略论生物遗传资源的法律保护[J];法制与社会;2010年04期
10 杨显滨;陈雨;苏U，
本文编号：2201598
本文链接：https://www.wllwen.com/falvlunwen/guojifa/2201598.html
